Bioceramic Sealer, Pulpectomy
Conditions
Keywords
pulpectomy, retained primary molars
Brief summary
The goal of this single arm clinical trial was to to explore the clinical feasibility and radiographic outcome of the injectable bioceramic sealer as an obturation material for primary molars with congenitally missing permanent successors. The main question it aimed to answer was: Does injectable bioceramic sealers can be used as an obturation material for primary molars with congenitally missing permanent successors? Researchers used a commercially available bioceramic sealer as a sole obturation material for pulpectomized primary molars with congenitally missing permanent successors Eligible participants underwent pulpectomy treatment and followed up at 3,6,12 and 24 months postoperatively to evaluate clinical and radiographic success.
Interventions
BIOLOGICALbioceramic sealer
the root canals were obturated solely with Ceraseal bioceramic sealer
Sponsors
Osama Seif El-Nasr Hussein Gad El-Hak
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
5 Years to 12 Years
Healthy volunteers
No
Inclusion criteria
* Healthy (ASA I or II) children. * Cooperative (Frankel behavior rating 3 or 4) children * children having at least one mandibular primary 2nd molar with deep carious lesion. * No radiographic evidence of the developing permanent successor on orthopantomogram. * Signs and symptoms typical of irreversible pulpitis or pulp necrosis. * patients with minimal crowding (1-3 mm) or perfect alignment according to the Little's Irregularity Index in the lower arch.
Exclusion criteria
* Non-restorable primary molars. * Primary molars with severe infra-occlusion. * Presence of iatrogenic or pathological perforation of the pulpal floor. * Post-deroofing presence of healthy vital pulp, presenting as uniformly reddish pink vascular tissue. * Preoperative radiograph showing signs of internal or external pathological root resorption. * Root canal calcification.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| number of participants with clinically successful treatment (Asymptomatic teeth) | 3 months postoperatively, 6 months postoperatively, 12 months postoperatively, 24 months postoperatively. | * The tooth is asymptomatic, with no pain or discomfort. * Absence of tenderness upon percussion or palpation. * No evidence of pathological tooth mobility, soft tissue swelling, sinus tract formation, or purulent discharge from the gingival margin. |
Countries
Egypt
Outcome results
None listed